NC
Highly rated in
29
conditions
Highly rated in
29
conditions
Check Dr. Naga P. Chalasani's experience treating your condition:
About Dr. Naga P. Chalasani

Naga Chalasani is a Gastroenterologist in Indianapolis, Indiana. Chalasani has been practicing medicine for over 35 years and is highly rated in 29 conditions, according to our data. His top areas of expertise are Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Hepatitis, Liver Transplant, and Endoscopy. He is licensed to treat patients in Indiana. Chalasani is currently accepting new patients.

His clinical research consists of co-authoring 367 peer reviewed articles and participating in 19 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Naga P. Chalasani it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Naga P. Chalasani accepts the following insurance:

  •  Ambetter
  •  Anthem
  •  CareSource
  •  MHS

Call to see if your plan is accepted.
Locations
550 University Blvd, Suite 1710, Indianapolis, IN 46202
Other Locations
10300 N Illinois St, Suite 1100, Indianapolis, IN 46290
Background & Education
Graduate Institution
Other, 1988
Specialties
Gastroenterology
Licenses
Internal Medicine in IN
Hospital Affiliations
IU Health Methodist Hospital
Witham Health Services
IU Health North Hospital
Union Hospital
IU Health Blackford Hospital
Languages Spoken
English
Hindi
Telugu
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


18 Clinical Trials

Alcoholic Hepatitis Network Observational Study
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
Effect of Heavy Alcohol Consumption on Farnesoid X Receptor (FXR) Signaling
Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV
Nonalcoholic Fatty Liver Disease (NAFLD) Database 3
Vitamin E Dosing Study (VEDS): A Dose Finding Study of Vitamin E for the Treatment of Adult NAFLD
A Multi-Center, Longitudinal Study of Drug-and CAM-Induced Liver Injury
The Effect of Vitamin E and Docosahexaenoic Acid Ethyl Ester on Non-Alcoholic Fatty Liver Disease (NAFLD) - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD)
Role of Exenatide in Treatment of NASH-a Pilot Study
2017-01: Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma
A Multicenter, Randomized, Double Blinded, Placebo-controlled Clinical Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis by the AlcHepNet Consortium
The Early Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding Due to Portal Hypertension
Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2
A Double-Blind, Placebo-Controlled Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH)
View 10 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors